title: Preservation of metabolic reserves and function after storage of myocytes in hypothermic UW solution.
abstract: Isolated rat myocytes cold stored anaerobically up to 24 h in University of Wisconsin solution lost 95% of their ATP and 100% of their glycogen. They underwent contracture when rewarmed in a Krebs-Henseleit (KH) medium that contained Ca unless Ca addition was delayed. In the latter case, cell function, measured by stimulation-induced cell shortening, was surprisingly well retained. Aerobically stored cells were resistant to Ca on rewarming, although 96% of glycogen was still lost, along with 46% of ATP. Cells that were incubated for 48 h aerobically with the substrates glucose and pyruvate at pH 6.2 retained 77% of their ATP and 59% of their glycogen, with good cell morphology. At pH 6.2, the demand for ATP was only 55% of that at pH 7.4. However, after rewarming, these cells functioned no better than anaerobically stored cells, although their inotropic response to isoproterenol was improved. We conclude that 1) aerobic conditions with substrates at low pH preserve myocyte metabolic reserves well for 48 h, partly by reducing the demand for ATP; 2) rewarming conditions are critical for anaerobically stored cells with metabolic stores that are severely depleted; and 3) unloaded cell function is surprisingly insensitive to a period of severe metabolic deprivation.
authors.affiliation: Department of Surgery, University of Wisconsin, Madison, Wisconsin 53792, USA.
authors.forename: J O
authors.initials: JO
authors.lastname: Hegge
authors.forename: J H
authors.initials: JH
authors.lastname: Southard
authors.forename: R A
authors.initials: RA
authors.lastname: Haworth
mesh_terms: D000241:Adenosine / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000378:metabolism; D000332:Aerobiosis; D000493:Allopurinol / Q000494:pharmacology*; D000693:Anaerobiosis; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002314:Cardioplegic Solutions / Q000494:pharmacology; D002478:Cells, Cultured; D005947:Glucose / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006863:Hydrogen-Ion Concentration; D007328:Insulin / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology*; D009206:Myocardium / Q000166:cytology* / Q000378:metabolism*; D019188:Organ Preservation Solutions; D010725:Phosphocreatine / Q000378:metabolism; D011887:Raffinose / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013696:Temperature; D014021:Tissue Preservation / Q000379:methods; D014325:Tromethamine / Q000494:pharmacology
chemical_list: D002314:Cardioplegic Solutions; D007328:Insulin; C074097:Krebs-Henseleit solution; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D010725:Phosphocreatine; D014325:Tromethamine; D000493:Allopurinol; D000255:Adenosine Triphosphate; D005978:Glutathione; D005947:Glucose; D000241:Adenosine; D011887:Raffinose; D002118:Calcium